An Act to create 95.75 of the statutes; Relating to: testing cosmetics on animals and providing a penalty.
Summary
AB1185 creates a new section of Wisconsin statutes to restrict cosmetic animal testing and the sale of cosmetics linked to such testing. The bill defines cosmetics, cosmetic ingredients, and cosmetic manufacturers, and generally bars a manufacturer from conducting or contracting for cosmetic animal testing in Wisconsin after December 31, 2026. It also prohibits manufacturing or importing into Wisconsin, and later selling or offering for sale in Wisconsin, cosmetics or ingredients that the manufacturer knows or reasonably should know were developed or manufactured using cosmetic animal testing conducted after that date.
The bill includes a phase-in period, with the sales prohibition taking effect on July 1, 2027. It also carves out several exceptions, including certain testing done to satisfy federal, state, or foreign regulatory requirements, testing involving products subject to specified federal Food, Drug, and Cosmetic Act provisions, and some noncosmetic testing conducted for other regulatory purposes. Violations are subject to a $5,000 forfeiture plus $1,000 for each day the violation continues.
Impact
AB1185 would add a new statutory prohibition in Wisconsin law governing cosmetic animal testing and the in-state sale and importation of certain cosmetics. It would affect cosmetic manufacturers, packers, distributors, and retailers by imposing compliance obligations tied to how products and ingredients were tested or developed, while also creating enforcement authority through civil forfeitures. The bill would not ban all animal testing generally; rather, it targets cosmetic-related testing and includes exceptions for specified regulatory and noncosmetic circumstances.
Sentiment
The available record suggests generally favorable or at least active support for the bill, as reflected by a broad list of assembly and senate cosponsors and no recorded committee opposition or votes in the provided materials. The bill’s introduction and cosponsorship pattern indicate interest in aligning Wisconsin with restrictions on cosmetic animal testing. No committee transcript is available, so there is no direct evidence of debate, but the absence of recorded dissent suggests the measure was not yet the subject of documented controversy in the provided context.
Contention
The main points of potential contention are the scope of the prohibitions and the exceptions. Manufacturers and industry stakeholders may be concerned about the practical burden of determining whether ingredients were developed using animal testing, especially for products sourced through complex supply chains. Another likely issue is the bill’s regulatory carve-outs, particularly the exceptions for compliance with federal, state, or foreign requirements and for products subject to certain federal law provisions, which may be viewed as either necessary flexibility or as loopholes that weaken the ban. The delayed effective dates also suggest an attempt to balance animal-welfare goals with industry transition concerns.